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a  b  s  t  r  a  c  t
The  important  industrial  chemical  1,3-butadiene  (BD;  CAS  Registry  Number:  106-99-0)  is a potent  car-
cinogen in B6C3F1  mice  and  a weak  one  in  Sprague-Dawley  rats.  This  difference  is mainly  attributed  to  the
species-speciﬁc  burden  by the  metabolically  formed  1,2:3,4-diepoxybutane  (DEB).  However,  only  limited
data exist  on the  DEB  blood  burden  of rodents  at BD  concentrations  below  100  ppm.  Considering  this,  DEB
concentrations  were  determined  in  the  blood  of  mice  and  rats  immediately  after  6 h exposures  to various
constant concentrations  of  BD  of  between  about  1 and  1200 ppm.  Immediately  after  its  collection,  blood
was  injected  into  a  vial  that  contained  perdeuterated  DEB  (DEB-D6) as  internal  standard.  Plasma  samples
were  prepared  and treated  with  sodium  diethyldithiocarbamate  that  derivatized  metabolically  produced
DEB and DEB-D6 to their  bis(dithiocarbamoyl)  esters,  which  were  then  analyzed  by high  performance
liquid  chromatography  coupled  with  an  electrospray  ionization  tandem  mass  spectrometer.  DEB  concen-at
iethyldithiocarbamate
C/MS/MS
trations  in  blood  versus  BD  exposure  concentrations  in  air could  be described  by one-phase  exponential
association  functions.  Herewith  calculated  (±)-DEB  concentrations  in blood  increased  in  mice  from
5.4 nmol/l  at  1  ppm  BD  to  1860  nmol/l  at 1250  ppm  BD  and  in rats  from  1.2 nmol/l  at 1 ppm  BD  to  92  nmol/l
at 200  ppm  BD,  at which  exposure  concentration  91%  of the  calculated  DEB  plateau  concentration  in rat
blood  was  reached.  This  information  on the species-speciﬁc  blood  burden  by  the  highly  mutagenic  DEB
 carcihelps to explain  why  the
. Introduction
The gaseous oleﬁn 1,3-butadiene (BD) is a major industrial
hemical used primarily in the production of synthetic rubbers
nd plastics. In 2010, its global production and consumption were
eported to have been approximately 10.5 million metric tons
IHS, 2011). Exposure to BD occurs not only at workplaces. The
eneral population is exposed to low concentrations of this gas,
hich is found in indoor and outdoor air, mainly as a product
rom tobacco smoking and from incomplete combustion of biomass
nd fuel (U.S. Environmental Protection Agency, 2002). In long-
erm carcinogenicity studies (6 h/d, 5 d/w, 2 y), inhaled BD was
eakly carcinogenic in Sprague-Dawley rats exposed to 0 ppm,
000 ppm or 8000 ppm (Owen et al., 1987) but was highly effective
y inducing tumors in B6C3F1 mice which were exposed to BD con-
∗ Corresponding author at: Institute of Toxicology, German Research Center for
nvironmental Health, Helmholtz Zentrum München, Ingolstädter Landstrasse 1,
-85764 Neuherberg, Germany. Tel.: +49 893 187 2977; fax: +49 893 187 3449.
E-mail address: johannes.ﬁlser@helmholtz-muenchen.de (J.G. Filser).
378-4274 © 2011 Elsevier Ireland Ltd. 
oi:10.1016/j.toxlet.2011.09.027
Open access under CC BY-NC-ND license.nogenic  potency  of  BD  in  rats  is low  compared  to that  in  mice.
© 2011 Elsevier Ireland Ltd. 
centrations of up to 625 ppm. In female mice, lung tumors increased
at a concentration as low as 6.25 ppm. In male mice, the lowest
BD concentration showing increased tumor incidences in several
organs was 62.5 ppm. In both genders, increased tumor incidences
were found in every investigated tissue at 200 ppm (Melnick et al.,
1990).
In order to understand the different carcinogenic potency of
BD in both species, its metabolism was thoroughly investigated
by several laboratories. BD is biotransformed by cytochrome P450
dependent monooxygenases (primarily CYP2E1) and the endo-
plasmic epoxide hydrolase to the three epoxide intermediates
1,2-epoxy-3-butene, 1,2:3,4-diepoxybutane (DEB), and 3,4-epoxy-
1,2-butanediol (reviewed in Himmelstein et al., 1997; Kirman et al.,
2010). In vivo metabolism of BD to 1,2-epoxy-3-butene was ﬁrst
shown by Bolt et al. (1983) and Filser and Bolt (1984) in BD
exposed rats. The three epoxides are genotoxic as was  demon-
strated in numerous studies carried out in vitro as well as in vivo
Open access under CC BY-NC-ND license.(reviewed in Albertini et al., 2010). DEB contains two electrophilic
sites and forms DNA–DNA and DNA–protein cross-link adducts
(Goggin et al., 2009; Michaelson-Richie et al., 2010). In cultured
human lymphoblasts, the mutagenic activity of DEB was  up to 100
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nd 350 times higher than those of 1,2-epoxy-3-butene and 3,4-
poxy-1,2-butanediol, respectively (Cochrane and Skopek, 1994).
lso, the carcinogenic potency of DEB was higher than that of 1,2-
poxy-3-butene in similarly treated Swiss mice (skin application,
 times per week, lifelong; Van Duuren et al., 1963, 1965).
In blood of BD exposed mice and rats, all three epoxides were
ound. In both species, 62.5 ppm was the lowest BD concentra-
ion at which DEB was determined (reviewed in Filser et al., 2007).
umans, however, are generally exposed to lower BD concentra-
ions: in the USA, European countries, Canada, China, Malaysia,
outh Africa, and New Zealand, occupational threshold limits for
-h time-weighted average workplace concentrations of BD are
etween 0.5 and 21 ppm (IARC, 2008).
Knowledge of the DEB concentrations in blood will be highly
elevant as a solid basis for the development of a valid physiolog-
cal toxicokinetic model that can be applied for risk assessment
urposes. In order to become informed about DEB in the blood
f mice and rats at BD concentrations that are more relevant to
uman exposure concentrations as well as for comparison with
ublished data, the aim of the present work was to quantify DEB in
he blood of mice and rats exposed over 6 h to various constant BD
oncentrations of between 1 and 1200 ppm.
. Materials and methods
.1. Chemicals
All commercial chemicals were purchased with the highest purity available.
ost of them were from Merck, Darmstadt, Germany, Riedel-deHaën, Seelze,
ermany, or Sigma–Aldrich, Taufkirchen, Germany. Gases were from Linde, Unter-
chleissheim, Germany. Liquemin N25000 (heparin-sodium) was  obtained from
offmann-La Roche, Grenzach-Wyhlen, Germany. Soda lime (Drägersorb 800 Plus)
as  from Drägerwerk, Lübeck, BD (99.5%) from Linde, racemic DEB (97%) and diethyl
aleate (DEM, 97%) from Sigma–Aldrich. Ketamine 10% (aqueous solution con-
aining 115.34 mg  ketamine hydrochloride per ml)  was  obtained from Intervet,
nterschleissheim and Rompun 2% (aqueous solution containing 23.32 mg xylazine
ydrochloride per ml)  from Bayer, Leverkusen, Germany. Sodium diethyldithio-
arbamate trihydrate (DTC, >99.0) was purchased from Fluka Chemie, Buchs,
witzerland. 1,2:3,4-Diepoxy-[1,1,2,3,4,4-D6]butane (DEB-D6), consisting of a mix-
ure of the (±)-form (2 parts) and the meso form (1 part) as conﬁrmed by
C/MS/MS-measurements, was custom made by Synthon, Augsburg, Germany. Han-
ling of all chemicals during different sample preparations was carried out under
he hood.
.2. Animals
Male Sprague-Dawley rats (240–290 g) and male B6C3F1 mice (20–30 g) were
urchased from Charles River Wiga GmbH, Sulzfeld, Germany. All experimental pro-
edures with animals were performed in conformity with the Guide for the care and
se of laboratory animals (NRC, 1996) under the surveillance of the authorized rep-
esentative for animal welfare of the Helmholtz Zentrum München. Animals were
cclimated for at least 3 days before exposure. They were housed in macrolon type
II  cages in an IVC top-ﬂow system (Tecniplast, Buguggiate, Italy) that provided them
ith  ﬁltered room air. Animals were kept at room temperature of between 22 and
5 ◦C receiving standard diet 1324 (Altromin, Lage, Germany) and tap water ad libi-
um. A light and dark cycle of 12 h and a relative air humidity of between 50% and
0%  were maintained in the animal room.
.3. Exposure experiments
Closed glass-spheres (63 l) were used for exposing animals to BD. The expo-
ure  system is described in detail in Filser et al. (2007).  Groups of mice or rats
ere exposed to mean atmospheric BD concentrations (±standard deviation) of
.0 (±0.17), 6.4 (±0.65), 11 (±1.2), 21 (±1.8), 63 (±6.8), 108 (±8.1), 311 (±24), 603
±35), or 1180 (±101) ppm (mice) and of 1.1 (±0.20), 2.4 (±0.67), 5.6 (±1.1), 11
±1.1), 21 (±1.1), 33 (±2.5), 62 (±8.9), 106 (±6.0), 203 (±11), 624 (±36), or 1220
±47) ppm (rats). During the exposure experiments, atmospheric BD concentrations
ere determined at varying time periods of between 6 and 14 min  and were main-
ained quasi-constant by repeatedly injecting gaseous BD (taken directly from the
as cylinder or as a diluted gas from a storage desiccator) to replenish the losses of
D in the gas-tight spheres, which resulted from metabolic elimination and from
pening the chamber for placing or removing an animal. At each exposure exper-
ment with mice, two groups of six animals each (tail-marked by different colors)
ere placed with an interval of 25 min  into one chamber. In experiments with rats,
 individually tail-marked animals were successively put into one chamber at timetters 207 (2011) 286– 290 287
intervals of 20 min. Rat exposures were carried out twice at BD concentrations of
1.1,  5.6, and 11 ppm. Each animal was  exposed for 6.0 h. Mice were sacriﬁced by
cervical dislocation. Using a disposable, heparin sodium-moistened syringe, up to
0.5  ml  of blood was  taken from the vena cava caudalis (near to the heart) of each ani-
mal  of a group and injected – one after the other – in one ice-cooled 5-ml-cryotube
vial (Simport, Beloeil, Quebec, Canada) that contained 40 l of an ethanolic solu-
tion  of the glutathione depleting agent DEM (515 l DEM in 2760 l ethanol) and
10  l (1.0 and 6.4 ppm BD) or 30 l (11–1180 ppm BD) of the internal standard
DEB-D6 (14.5 mol/l in acetone). The vial was shaken after each blood injection.
The whole procedure of pooling the blood of the 6 mice per group lasted not more
than 6 min. Rats were treated according to Lee et al. (2005).  Twenty minutes before
sacriﬁcing a rat, it was removed from the sphere and immediately anesthetized by
injecting intraperitoneally a mixture consisting of 0.88 ml ketamine/kg body weight
and 1.1 ml  Rompun/kg body weight. Directly thereafter, the anesthetized animal was
returned into the exposure sphere. Within 5 min, the target concentration was read-
justed by compensating for the amount of BD being lost. At the end of the exposure,
the anesthetized animal was removed from the sphere and sacriﬁced immediately.
Within 1 min  after sacriﬁce, about 4 ml  of blood was collected from the vena cava
caudalis (near to the heart) by means of a heparin sodium-moistened syringe, and
injected in an ice-cooled 5-ml-cryotube vial that contained 40 l of the DEM solu-
tion  and 10 l (1.1–5.6 ppm BD) or 30 l (11–1220 ppm BD) of DEB-D6 (14.5 mol/l
in  acetone). The vial was closed and shaken vigorously.
The ice-cold blood samples were immediately centrifuged at 0 ◦C and plasma
was  stored at −80 ◦C until sample preparation for DEB analysis.
2.4.  Analytical methods
2.4.1. 1,3-Butadiene
During the exposures, BD was determined directly from 5-ml gas samples that
were collected by means of disposable syringes from the chamber air and imme-
diately injected via a 300 l sample loop on column in a Shimadzu GC-8A gas
chromatograph (GC; Shimadzu, Duisburg, Germany) equipped with a ﬂame ioniza-
tion detector using nitrogen with a pressure of 3.75 kg/cm2 as carrier gas. Separation
was done on a stainless steel column (3.5 m × 1/8 in. × 2 mm)  packed with Tenax TA
(60–80 mesh; Chrompack, Frankfurt, Germany). Temperatures of column oven and
detector were 110 ◦C and 200 ◦C, respectively. The combustible gases were hydro-
gen  and synthetic air, each with a pressure of 0.6 kg/cm2. Under these conditions,
the  retention time of BD was 3.8 min. Chromatograms were recorded and integrated
by  a CR5A integrator (Shimadzu). Calibration curves were constructed several times
by generating BD gas concentrations ranging from 1 to 2000 ppm in atmospheres of
closed chambers. Calibration curves were linear in the whole range. Analysis of lin-
ear regression through the origin revealed correlation coefﬁcients (r) of at least 0.997
between peak areas and atmospheric BD concentrations. Each time before starting
a  BD exposure, a one-point calibration was  carried out in the concentration range
used in the actual experiment. The limit of detection (three times the background
noise) was 0.3 ppm. The coefﬁcient of variation, as a measure for reproducibility,
was determined from 6 measurements each carried out at BD concentrations that
covered the whole concentration range studied. It was always below ±2.7%.
2.4.2. 1,2:3,4-Diepoxybutane
2.4.2.1. Sample preparation. The DEB determination was based on the derivatization
with DTC (according to Munger et al., 1977; Dupard-Julien et al., 2007). The deriva-
tization procedure was species-speciﬁc. Mice: To 0.5 ml  of thawed plasma, 1 ml of a
DTC solution (0.22 mol/l in a 50 mmol/l phosphate buffer of pH 7.4) was  added. After
vortexing vigorously, the mixture stood for 10 min at room temperature, then for
1  h at 50 ◦C. After cooling to room temperature, the obtained bis(dithiocarbamoyl)
esters were extracted twice with 2 ml chloroform each. To the uniﬁed organic phase
1  ml  of an aqueous sodium chloride solution (10 g/100 ml) was added and the mix-
ture was  vortexed thoroughly for 0.5 min. After centrifuging, the organic phase
was  carefully removed, dried in a gentle stream of nitrogen, resuspended in 50 l
methanol, and transferred in an autosampler vial for LC/MS/MS analysis. Rats: To
2  ml  of thawed plasma, 1 ml  of a DTC solution (1.78 mol/l in a 50 mmol/l phosphate
buffer, pH 7.4) was added, followed by vortexing. After standing for 1 h at room
temperature, 1 ml  of acetonitrile was added. The mixture stood for further 10 min,
followed by vortexing and centrifugation. The supernatant was transferred to a new
vial. The pellet was  vortexed for about 30 s in 1 ml  of acetonitrile, centrifuged, and the
supernatant was  uniﬁed with the already transferred one. Thereafter, 300 mg NaCl
was  given to the 2–3 ml  of the uniﬁed aqueous acetonitrilic solution which was then
twice extracted with 3 ml  chloroform each. After drying under a stream of nitrogen,
the  residue was solved in 40 l methanol and transferred to an autosampler vial for
LC/MS/MS analysis.
2.4.2.2. LC/MS/MS analysis. From an autosampler vial containing the DEB- and
DEB-D6-bis(dithiocarbamoyl) esters 5 l was  subjected to LC/MS/MS analysis. The
LC/MS/MS system consisted of an HP1100 liquid chromatograph (Agilent, Wald-
bronn, Germany) and an API 4000 triple quadrupole mass spectrometer with turbo
ion  spray interface (Applied Biosystems, Darmstadt, Germany). The liquid chro-
matograph was  equipped with a Luna C18 (2) column (150 mm × 2 mm i.d., 5 m)
obtained from Phenomenex, Aschaffenburg, Germany. Separation was  carried out
with retention times of around 7.1 min (racemic DEB and (±)-DEB-D6) and 8.0 min
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meso-DEB and meso-DEB-D6) at 30 ◦C (column oven) with a ﬂow of 300 l/min
sing a mobile phase consisting of aqueous ammonium acetate (5 mmol/l, pH = 7.0;
olvent A) and methanol (solvent B). The composition of the solvents was  A = 40%
nd B = 60% for the ﬁrst 5 min. Up to 8 min, the percentage of B increased linearly to
00% and remained up to 23 min. Within 2 min, the composition of the buffer was
hen adjusted back to A = 40% and B = 60%. The column was ready for a new injection
fter 30 min.
The turbo ion spray source of the API 4000 was  operated at a temperature of
70 ◦C in the positive ionization mode at an ion spray voltage of 4400 V. Nitro-
en  served as curtain (CUR = 10), nebulizing (GS1 = 35, GS2 = 45), and collision gas
CAD = 7). The mass spectrometer was used in the multiple reaction-monitoring
ode. Unit resolution (at half peak height) was used for both Q1 and Q3. For identi-
cation and quantiﬁcation, the peak area of the transition ion at m/z 385.2 → 367.2
dwell time 150 ms,  declustering potential = 50 V, collision energy = 17 V) was  moni-
ored for the DEB-derivative relative to that at m/z 391.1 → 373.1 (dwell time 150 ms,
eclustering potential = 50 V, collision energy = 19 V) monitored for the DEB-D6-
erivative. Additional fragmentation reactions (385.2 → 116.2 and 391.1 → 116.2)
ere used as qualiﬁers. Data processing was done by means of the software Analyst
.4.2 from Applied Biosystems. A product ion spectrum of the DEB-diester is shown
n  Fig. 1.
For constructing a DEB-calibration curve consisting of 10 DEB concentrations
mice) or 9 DEB concentrations (rats) that ranged from 0 to 0.08 mol/l blood or
rom 0 to 2.0 mol/l blood (mice) and from 0 to 0.0035 mol/l blood or from 0 to
.4  mol/l blood (rats), blood of naïve animals (about 30 mice or 10 rats) was pooled.
lood samples were treated as described under Section 2.3 with the difference that
etween 5 and 20 l of an acetonic solution of a predeﬁned concentration of racemic
EB  was  added into the samples before the preparation of plasma. In total, four
alibration curves were constructed for mice and eight calibration curves for rats.
inear regression analyses revealed coefﬁcients of determination (R2) of between
.992 and 0.999. The limits of detection of DEB (3 times the background noise) were
 nmol/l (mouse blood) and 0.3 nmol/l (rat blood).
. Results and discussionFig. 2 shows (±)-DEB and meso-DEB in the blood of BD exposed
ice (Fig. 2A and a) and rats (Fig. 2B and b). All measured
ata are given in Fig. 2A and B, excerpts demonstrating DEB
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ig. 2. DEB concentrations in blood of mice (A, a) and rats (B, b) after exposures (6 h) to con
xposed together to each concentration. Four rats were exposed together to BD concentr
o  concentrations of 1.1 ppm, 5.6 ppm, and 11 ppm. Whole exposure ranges are represen
±)-DEB; (×) meso-DEB; (A, a) two values per exposure concentration (each from pooled
deviation bars, except when smaller than the symbol size) from 4 rats or from 8 rats. Li
ines  are one-phase exponential association functions (y = y∞[1 − e−kx]) that were ﬁtted t
alculated (±)-DEB concentrations in blood (y∞) are 1.92 mol/l in mice (95% conﬁdence i
he  values of k for (±)-DEB were 0.00284/ppm BD in mice (95% conﬁdence intervals 0.0
aximum meso-DEB concentrations in blood (y∞) were 0.0977 mol/l in mice (95% conﬁ
.0042–0.0054). The values of k for meso-DEB were 0.00175/ppm BD in mice (95% conﬁd
.0087–0.020). The squares of the correlation coefﬁcients (R2) for (±)-DEB were 0.981 in Fig. 1. Product ion spectrum of the bis(N,N-diethyldithiocarbamoyl) ester of DEB
(m/z = 385.2). Presumed products are shown. The instrumental parameters are given
in  the text.
concentrations at low BD exposure concentrations of between
0 and 21 ppm are given in Fig. 2a and b. Large standard errors
are seen in rats. The individual rat data may reﬂect the fact that
DEB is only a minor second-order BD metabolite in the rat liver
(Filser et al., 2010). In mice, the ﬁgure shows only small differences
in the means of two  groups of 6 animals each, both of which
were exposed identically. In non-exposed control animals of
both species, there was no DEB background. Also no DEB-related
background was  found by Georgieva et al. (2010) who  investigated
DEB-characteristic adducts at the N-terminal valine of hemoglobin
(N,N-(2,3-dihydroxy-1,4-butadiyl)-valine) in mice and rats
B
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stant concentrations of BD. Twelve mice, subdivided in 2 groups of 6 animals, were
ations of 2.4 ppm, 21 ppm, and above and two times 4 rats were exposed together
ted by the letters A and B, extracts by a and b. Symbols give measured data: ()
 blood of 6 mice), identical values at 3 exposure concentrations; (B, b) means ± SE
mits of detection were 0.001 mol/l (mouse blood) and 0.0003 mol/l (rat blood).
o the data. The variable x stays for the BD exposure concentration (ppm). Maximum
ntervals 1.62–2.22) and 0.101 mol/l in rats (95% conﬁdence intervals 0.091–0.11).
017–0.0040) and 0.0122/ppm BD in rats (95% conﬁdence intervals 0.0085–0.016).
dence intervals 0.029–0.17) and 0.00478 mol/l in rats (95% conﬁdence intervals
ence intervals 0.000–0.0043) and 0.0146/ppm BD in rats (95% conﬁdence intervals
mice and 0.975 in rats. For meso-DEB, they were 0.881 in mice and 0.949 in rats.
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epeatedly exposed over 2 weeks to BD concentrations of between
 and 625 ppm. In mice, measured (±)-DEB blood concentrations
eem to reach a plateau concentration of about 1.74 mol/l at
00 ppm BD. In rat blood, mean concentrations of (±)-DEB amount
o not more than 0.1 mol/l. Of this concentration, 70% is reached
t 100 ppm BD.
The curves, also shown in the ﬁgure, were ﬁtted to the data by
eans of Prism 5 for Mac  OS X (GraphPad Software, La Jolla, Cal-
fornia) using one-phase exponential association functions. These
unctions were preferred to Michaelis–Menten functions because
hey provided higher correlation coefﬁcients. The (±)-DEB blood
oncentrations in mice, calculated by means of the one-phase expo-
ential association function, increased from 5.4 nmol/l at 1 ppm
D to 1860 nmol/l at 1250 ppm BD. In rats, they increased from
.2 nmol/l at 1 ppm BD to 92 nmol/l at 200 ppm BD. At this exposure
oncentration, 91% of the calculated DEB plateau concentration in
at blood was reached.
In both species, the blood concentrations of the (±) form are
uch higher than those of the meso form. The ratio of (±)- to meso-
EB is similar in mice and rats and does not change very much
n the whole exposure range. It is between 21 and 32 in mouse
lood and between 17 and 21 in rat blood. Goggin et al. (2009)
etermined DNA–DNA cross-link adducts (1,4-bis-(guan-7-yl)-2,3-
utanediol) of racemic and meso-DEB in livers of female mice and
ats exposed repeatedly (6 h/d, 5 d/w, 2 w) to BD concentrations of
p to 625 ppm. In both species, the cross-link adducts from meso-
EB were much less than those from racemic DEB, which is in
greement with the present data on blood concentrations of (±)-
nd meso-DEB.
The DEB plateaus (Fig. 2) do not result from saturation of
YP2E1 mediated oxidation of its metabolic precursor EB, con-
idering that the Michaelis constant of this metabolic step is
round 140 mol/l in liver microsomes of both rodent species
Seaton et al., 1995). Most probably, the experimentally demon-
trated concurrent metabolic interactions of BD and its metabolites
,2-epoxy-3-butene and 3-butene-1,2-diol at the metabolizing
ytochrome P450 species (Filser et al., 2010) are the main cause
or these plateaus occurring in both animal species at very low DEB
oncentrations of less than 2 mol/l. For a more detailed discussion
ee Filser et al. (2007).
The present DEB mouse data can be compared to DEB blood
oncentrations that had been published for the same strain. After
ingle exposures (between 4 and 6 h) of male mice to BD concen-
rations of between 62.5 and 1270 ppm (Bechtold et al., 1995; Filser
t al., 2007; Himmelstein et al., 1994; Thornton-Manning et al.,
995a), DEB concentrations were reported that are between 77%
nd 209%, on average 121%, of the values calculated for identical
D exposure concentrations by means of the exponential func-
ion ﬁtted to the data given in Fig. 2A and a. So far, only one
roup reported measured DEB concentrations in BD exposed rats.
fter a vacuum line-cryogenic distillation of the blood of male
prague-Dawley rats exposed to a BD concentration of 62.5 ppm,
EB concentrations of 5 nmol/l (Thornton-Manning et al., 1995a)
nd of 2.4 nmol/l (Thornton-Manning et al., 1995b)  had been deter-
ined by gas chromatography using a mass selective detector
perating in selected ion monitoring mode. By means of the same
ethod, DEB blood concentrations of up to 17 nmol/l had been
ound in female Sprague-Dawley rats exposed either once (6 h) or
epeatedly (6 h/d, 10 d) to 62.5 ppm or 8000 ppm BD (Thornton-
anning et al., 1995a,b, 1997, 1998). These DEB concentrations are
rastically lower than those of about 50 nmol/l at 62.5 ppm and
00 nmol/l at ≥200 ppm detected in the present work by means of
he distinctly more selective LC/MS/MS method compared to that
f Thornton-Manning and co-workers.
Although the present data were obtained after single 6-h BD
xposures of male animals and those of Goggin et al. (2009) andtters 207 (2011) 286– 290 289
Georgieva et al. (2010) after repeated (6 h/d, 5 d/w, 2 w)  BD expo-
sures of female animals, it may  be meaningful to compare the
ratios mouse-to-rat, calculated from the present (±)-DEB blood
concentrations to the calculated ratios mouse-to-rat of racemic 1,4-
bis-(guan-7-yl)-2,3-butanediol in livers (Goggin et al., 2009) and
of N,N-(2,3-dihydroxy-1,4-butadiyl)-valine in blood (Georgieva
et al., 2010). The inter-gender comparison is justiﬁed because the
amounts of cross-link adducts were 2–2.5-fold higher in females
of both species compared to males when subjected to the same
exposure conditions (Goggin et al., 2009). The ratio of (±)-DEB in
mouse blood compared to rat blood increases from 4.5 at near to
0 ppm BD up to 16 at 625 ppm BD (calculated using the one-phase
exponential association functions). The ratio of 1,4-bis-(guan-7-
yl)-2,3-butanediol increases from 4.2 at 62.5 ppm BD up to 11 at
625 ppm BD. In the exposure range between 0.5 and 625 ppm BD,
ratios of between 6 and 15 can be calculated for the DEB exposure
marker N,N-(2,3-dihydroxy-1,4-butadiyl)-valine. All three studies
show that the DEB burden is substantially higher in mice than
in rats and that the difference increases at BD concentrations
above 200 ppm. Not expected from the present DEB data are the
drastically larger mouse-to-rat ratios in the N,N-(2,3-dihydroxy-
1,4-butadiyl)-valine levels which were reported for longer BD
exposures (6 h/d, 5 d/w, 4 w) (Georgieva et al., 2010; Swenberg
et al., 2007). It has been speculated that the exposure of the ery-
throcytes to DEB decreased the lifespan of the rat erythrocytes
and diluted the adduct levels in rat erythrocytes by increased
hematopoiesis (Georgieva et al., 2010).
The present data help to explain the ﬁndings on the species-
speciﬁc carcinogenic potency of BD in mice and rats. In blood of
male rats, mean concentrations of DEB do not surpass 0.1 mol/l, a
concentration reached at an exposure concentration of 19 ppm in
blood of male mice. In male mice, the lowest statistically signiﬁcant
carcinogenic BD exposure concentration was 62.5 ppm in a two-
year inhalation study (Melnick et al., 1990), which corresponds to
a DEB concentration of 0.3 mol/l in blood. Considering that male
rats never reach this blood concentration, it seems probable that
BD induced gland tumors in rats exposed to 1000 and 8000 ppm
BD (Owen et al., 1987) resulted not so much from the DEB  bur-
den but primarily from the burdens of both 1,2-epoxy-3-butene
and 3,4-epoxy-1,2-butanediol as has already been suggested earlier
(Filser et al., 2007; Fred et al., 2008). In the blood of rats, concentra-
tions of 1,2-epoxy-3-butene and 3,4-epoxy-1,2-butanediol of about
1 mol/l and 2 mol/l, respectively, are found at BD concentrations
of 1000 ppm (Filser et al., 2007).
As a starting point for the estimation of the risk of BD to humans
who may be exposed to low BD concentrations, knowledge of
the internal burden by the epoxy-metabolites of BD is required.
In addition to the earlier sensitive methods for the determina-
tion of 1,2-epoxy-3-butene and 3,4-epoxy-1,2-butanediol in blood
(Filser et al., 2007, 2010), we  have now a very sensitive and highly
speciﬁc method for the analysis of DEB in our hands. Consider-
ing the larger blood volumes that can be collected from humans
compared to individual rodents, the novel method demonstrated
here may  be sensitive enough to quantify DEB in blood of BD
exposed humans even if this substance is present at up to 9-fold
lower concentrations than in rats as had been estimated (Kirman
et al., 2010). Data on blood concentrations of the three epoxides in
BD-exposed humans will also support the use of a chemical spe-
ciﬁc toxicokinetic adjustment factor over the default factor in the
dose–response assessments reducing the uncertainty in BD risk
assessments.Conﬂict of interest statement
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